JAK1 and T-cell acute lymphoblastic leukemia: For example, an activating mutation F734L in JAK1, found in a sample from a T-cell acute lymphoblastic leukaemia patient42, 43, maps in the β7–β8 loop of the pseudokinase domain that interacts with the β2–β3 loop of the kinase domain18, 41.